Feature | Strata | SCC (n = 191) | AC (n = 879) | SCLC (n = 179) |
Age (years) | <40 | 4 (2.09%) | 64 (7.28%) | 7 (3.91%) |
| 41 - 50 | 10 (5.24%) | 121 (13.77%) | 16 (8.94%) |
| 51 - 60 | 61 (31.94%) | 256 (29.12%) | 61 (34.08%) |
| 61 - 70 | 75 (39.27%) | 298 (33.90%) | 62 (34.64%) |
| >70 | 41 (21.47%) | 140 (15.93%) | 33 (18.44%) |
Sex | Female | 26 (13.61%) | 260 (29.58%) | 30 (16.76%) |
| Male | 165 (86.39%) | 619 (70.42%) | 149 (83.24%) |
Residence | East | 4 (2.09%) | 26 (2.96%) | 6 (3.35%) |
| North |
| 4 (0.46%) | 1 (0.56%) |
| OS | 5 (2.62%) | 17 (1.93%) | 5 (2.79%) |
| South | 179 (93.71%) | 818 (93.06%) | 166 (92.74%) |
| West | 2 (1.05%) | 10 (1.14%) | 1 (0.56%) |
BMI | 25 - 30 | 18 (9.42%) | 60 (6.83%) | 16 (8.94%) |
| 30 - 35 | 3 (1.57%) | 15 (1.71%) | 3 (1.68%) |
| 35 - 40 | 1 (0.52%) | 4 (0.46%) | 2 (1.12%) |
| <25 | 61 (31.94%) | 193 (21.96%) | 61 (34.08%) |
Method of diagnosis | Biopsy | 29 (15.18%) | 114 (12.97%) | 59 (32.96%) |
| Bronchoscopy | 2 (1.05%) | 4 (0.46%) | 1 (0.56%) |
| Cytology | 5 (2.62%) | 21 (2.39%) | 7 (3.91%) |
| Histopathology | 159 (83.25%) | 748 (85.10%) | 112 (62.57%) |
Stage | IA |
|
| 1 (0.56%) |
| IB |
| 2 (0.23%) |
|
| II |
| 2 (0.23%) |
|
| IIA |
| 2 (0.23%) |
|
| IIB | 1 (0.52%) | 3 (0.34%) | 1 (0.56%) |
| III | 5 (2.62%) | 18 (2.05%) | 3 (1.68%) |
| IIIA | 4 (2.09%) | 7 (0.80%) | 4 (2.23%) |
| IIIB | 11 (5.76%) | 13 (1.48%) | 11 (6.15%) |
| IIIC |
| 2 (0.23%) |
|
| IV | 82 (42.93%) | 397 (45.16%) | 96 (53.63%) |
| IVA | 3 (1.57%) | 3 (0.34%) | 2 (1.12%) |
| IVB | 1 (0.52%) | 5 (0.57%) | 2 (1.12%) |